Free Trial

Ryman Healthcare (OTCMKTS:RYHTY) Sets New 52-Week Low - Here's What Happened

Ryman Healthcare logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • New 52-week low: Ryman Healthcare's ADR fell to $6.33 in mid-day trading Friday (previous close $7.0087) on just 303 shares traded.
  • Trading below key averages: The stock is under both its 50‑day and 200‑day moving averages of $7.73, indicating short- and long-term weakness.
  • Fundamentals and business model: The New Zealand retirement-village developer and aged-care operator reports a low current and quick ratio of 0.17 with a debt-to-equity of 0.40, suggesting liquidity constraints despite moderate leverage.
  • Five stocks to consider instead of Ryman Healthcare.

Ryman Healthcare Ltd. Unsponsored ADR (OTCMKTS:RYHTY - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Friday . The company traded as low as $6.33 and last traded at $6.33, with a volume of 303 shares. The stock had previously closed at $7.0087.

Ryman Healthcare Stock Performance

The company has a debt-to-equity ratio of 0.40, a current ratio of 0.17 and a quick ratio of 0.17. The company's fifty day moving average is $7.73 and its 200 day moving average is $7.73.

About Ryman Healthcare

(Get Free Report)

Ryman Healthcare OTCMKTS: RYHTY is a New Zealand–based developer, owner and operator of retirement communities, offering residents independent living apartments, care suites and a full continuum of aged-care services. Through its portfolio of villages, Ryman provides retirement living together with on-site healthcare support ranging from rest home and dementia care to hospital-level services. Its integrated model combines property development with aged-care operations, delivering long-term accommodation solutions tailored to the needs of seniors.

Founded in the mid-1980s and publicly listed on the New Zealand and Australian stock exchanges, Ryman Healthcare has grown to become one of the country's leading retirement-village operators.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ryman Healthcare Right Now?

Before you consider Ryman Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryman Healthcare wasn't on the list.

While Ryman Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines